Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:company
|
| gptkbp:focusesOn |
AI-driven drug discovery
|
| gptkbp:foundedBy |
Samuel Hasson
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Redesign Science
|
| gptkbp:industry |
gptkb:biotechnology
drug discovery |
| gptkbp:notableFor |
using computational methods for drug design
|
| gptkbp:operatesIn |
gptkb:United_States
|
| gptkbp:website |
https://www.redesignscience.com/
|
| gptkbp:bfsParent |
gptkb:David_Rooklin
|
| gptkbp:bfsLayer |
6
|